Furosemide Uses in CKD/AKI
Indications and Contraindications
- The KDIGO guidelines strongly recommend (1B evidence) not using diuretics to prevent AKI, as randomized controlled trials and meta-analyses demonstrate that furosemide does not prevent AKI and may increase mortality when used for prevention 1
- KDIGO suggests (2C evidence) not using diuretics to treat AKI except in the management of volume overload 1
Dosing Considerations
- Patients with parenchymal renal disease may require dose adjustments of diuretic combinations 2
- In patients with severe bilateral renal artery stenosis, there is a risk of acute renal failure with diuretic use 3
Practical Administration
- For management of edema in renal disease, initial oral dosing is typically 20-80 mg/day, which can be increased based on response 4
- Monitor electrolytes (particularly potassium) shortly after initiating therapy and periodically thereafter 4
- Assess renal function regularly, as high doses of intravenous furosemide can cause acute reduction in renal perfusion and subsequent azotemia 5
Special Considerations
- In resistant cases, combination with other diuretic classes may be necessary 6
- Spironolactone may be used in combination with furosemide, but patients with CKD may tolerate less spironolactone due to hyperkalemia risk 6